Progesterone Vaginal Insert, 100 mg

Xiromed’s Progesterone Vaginal Insert, 100 mg is a prescription progesterone product intended for use as part of an Assisted Reproductive Technology (ART) treatment program. It is indicated to support embryo implantation and early pregnancy by supplementing corpus luteal function in women experiencing infertility. The product contains 100 mg of progesterone in a vaginal insert dosage form and is supplied with disposable applicators for administration.

Progesterone is a naturally occurring hormone that plays an important role in the reproductive cycle and in preparing the uterine lining for pregnancy. During an ART treatment program, a healthcare professional may prescribe progesterone supplementation to support the hormonal conditions needed after oocyte retrieval and embryo transfer. The appropriate treatment schedule, duration, and monitoring plan are determined by the prescribing healthcare professional based on the patient’s treatment protocol and clinical needs.

Progesterone Vaginal Insert, 100 mg for Assisted Reproductive Technology

The Progesterone Vaginal Insert, 100 mg is designed for vaginal administration under the direction of a qualified healthcare professional. According to prescribing information for progesterone vaginal inserts, the product may be used to support embryo implantation and maintain early pregnancy as part of an ART treatment program. Treatment protocols can vary, so patients should follow the exact instructions provided by their fertility specialist or prescribing clinician.

The vaginal route delivers progesterone locally through the vaginal mucosa. This dosage form may be selected by a healthcare professional as part of an individualized fertility treatment plan. Patients should not change the amount used, the frequency of administration, or the length of therapy unless instructed by their healthcare provider.

Progesterone therapy in an ART program is typically initiated according to the timing of the fertility procedure. Product labeling for progesterone vaginal inserts describes administration beginning after oocyte retrieval and continuing for a specified period based on the treatment plan. The prescribing information should always be consulted for complete dosing instructions, treatment duration, warnings, precautions, contraindications, and potential adverse reactions.

Progesterone Vaginal Insert, 100 mg Product Details

Xiromed’s Progesterone Vaginal Insert, 100 mg is supplied as a box containing 21 vaginal inserts and 21 disposable applicators. The product is listed under NDC 70700-201-70. The inserts are described as yellowish-white and oblong in shape, with product markings identified in the product information. The package is intended to provide a convenient supply for a prescribed course of treatment, although the actual duration of use depends on the patient’s individualized ART protocol.

The product should be stored at controlled room temperature between 20°C and 25°C, equivalent to 68°F and 77°F. Patients and healthcare professionals should follow the storage instructions provided with the product and keep the medication in its original packaging until use. Do not use a product that appears damaged, altered, or improperly stored without first contacting a pharmacist or healthcare professional.

The disposable applicators included in the package are intended to help facilitate administration. Patients should receive instructions from their healthcare provider or pharmacist regarding the correct use, handling, and disposal of the applicators. Used applicators should be discarded in accordance with local healthcare waste and household disposal guidance.

Progesterone Vaginal Insert, 100 mg and Patient Support

Fertility treatment can involve carefully timed medications, procedures, and follow-up visits. Patients using Progesterone Vaginal Insert, 100 mg should maintain communication with their fertility care team throughout treatment. It is important to report questions, unexpected symptoms, or difficulty administering the product to the prescribing healthcare professional.

Patients should use progesterone exactly as prescribed. Missing a dose, using more than directed, or stopping treatment without medical guidance may affect the treatment plan. If a dose is missed, the patient should contact their healthcare provider or follow the instructions supplied with the prescription rather than independently adjusting the schedule.

As with any prescription medicine, progesterone vaginal inserts may not be appropriate for everyone. Before treatment begins, patients should tell their healthcare provider about all medical conditions, allergies, prescription medicines, nonprescription products, vitamins, and supplements they use. The healthcare professional should also be informed about any history that may be relevant to progesterone treatment or pregnancy care.

The full prescribing information includes important safety considerations and should be reviewed before use. Patients should seek immediate medical attention for serious or unexpected symptoms and should contact their healthcare provider with questions about side effects, treatment response, or administration. Xiromed provides medical information and product-quality support for healthcare professionals and patients through its established contact channels.

Why Healthcare Professional Guidance Matters

Progesterone Vaginal Insert, 100 mg is intended for prescription use within a structured fertility treatment program. It is not a general fertility supplement and should not be used without an appropriate prescription and clinical guidance. The product’s indication, dose, timing, and treatment duration must be determined by a qualified healthcare professional.

A fertility specialist can explain how progesterone fits into an ART treatment plan, including when therapy begins, how it should be administered, and how long it should continue. Follow-up appointments may be used to evaluate the treatment plan and determine whether therapy should be continued, adjusted, or stopped. Individual results can vary, and the use of progesterone does not guarantee implantation, pregnancy, or a live birth.

Patients should rely on the product’s official prescribing information and their healthcare provider’s instructions for decisions about treatment. Online product content is intended to provide general information and does not replace medical advice, diagnosis, or individualized care.

Xiromed’s Progesterone Vaginal Insert, 100 mg offers healthcare professionals an additional prescription option for progesterone supplementation within ART treatment programs. With a 100 mg vaginal insert dosage form and a package that includes disposable applicators, the product is designed to support administration according to a prescribed fertility care plan. For complete information about approved use, dosing, administration, storage, contraindications, warnings, precautions, and adverse reactions, consult the official prescribing information and speak with a qualified healthcare professional.

This content should undergo medical, legal, and regulatory review before publication and should be aligned with the current approved prescribing information.